Anonymous
Guest
Anonymous
Guest
The SF territory is no joke. If the goal is to get your drug on formulary within a specified period of time, you have to contend with access issues, the fact that they aren't going to convene a special P&T meeting just to review your drug, apathy, and a general disdain for reps, especially at the academic institutions. So "getting it done" sometimes simply cannot happen due to dynamics in the territory. I think Stanford is doing well, but they were also involved in the studies, or at least I think they were. In the city you have CPMC, San Fran General, and UCSF being the main accts. They just don't invite you in and tell you that they will start using your product. I used to live there and called on SF exclusively, and this was 4 years ago. It was hard then, and I'm sure it's more of a bitch at this point. I know reps that are still there and successful, but they have both been there for 10 years and have rock-hard relationships in the same space. Be careful what you wish for.
Why you have a hard-on for this thread is a mystery. Can you please let it die, so we can go back to bitching about not making any money? We get it you are the SF pharmaceutical market guru, now please, go away.